GUT MICROBIAL METABOLISM OF 5-ASA IS PROSPECTIVELY ASSOCIATED WITH TREATMENT FAILURE

被引：0
|
作者：
Mehta, Raaj S.
Mayers, Jared R.
Zhang, Yancong
Bhosle, Amrisha
Nguyen, Long H.
Ma, Wenjie
Ananthakrishnan, Ashwin
Franzosa, Eric A.
Balskus, Emily
Chan, Andrew T.
Huttenhower, Curtis
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
273
引用
收藏
页码：S48 / S49
页数：2
相关论文
共 50 条
  • [41] RELAPSE RATES AFTER SUCCESSFUL TREATMENT OF REFRACTORY COLITIS WITH 5-ASA ENEMAS
    HANAUER, SB
    SCHULTZ, PA
    GASTROENTEROLOGY, 1987, 92 (05) : 1424 - 1424
  • [42] SULFASALAZINE LUNG - DESENSITIZATION TO SULFASALAZINE AND TREATMENT WITH ACRYLIC COATED 5-ASA AND AZODISALICYLATE
    SULLIVAN, SN
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1987, 9 (04) : 461 - 463
  • [43] Efficacy of Oral Mesalamine Monotherapy (5-ASA) versus Combination Oral Mesalamine Plus Proton Pump Inhibitor (5-ASA/PPI) Therapy in the Treatment of Ulcerative Colitis (UC)
    Lichtenstein, Gary
    Marchioni, Renee
    Blonski, Wojciech
    Mudireddy, Prashant
    Buchner, Anna
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S630 - S631
  • [44] NEW THERAPEUTIC MODALITIES IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE (IBD) - 4-ASA OR 5-ASA
    ALLGAYER, H
    KLOTZ, U
    BOHNE, P
    SCHMIDT, M
    KRUIS, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1994, 32 (11): : 647 - 650
  • [45] Use of 5-ASA is associated with decreased risk of dysplasia and colon cancer in ulcerative colitis
    Rubin, DT
    Djordjevic, A
    Huo, D
    Yadron, N
    Hanauer, SB
    GUT, 2004, 53 : A119 - A119
  • [46] EICOSANOID PRODUCTION BY THE MUCOSA IN INFLAMMATORY BOWEL-DISEASE AFTER 5-ASA TREATMENT
    ZIJLSTRA, FJ
    VANDIJK, APM
    OUWENDIJK, RJT
    VANRIEMSDIJKOVERBEEKE, IC
    WILSON, JHP
    AGENTS AND ACTIONS, 1993, 38 : C122 - C124
  • [47] 5-aminosalicylic acid (5-ASA) inhibits luminal sulfide production by gut bacteria in ulcerative colitis.
    Pitcher, MCL
    Beatty, ER
    Cummings, JH
    GASTROENTEROLOGY, 1996, 110 (04) : A992 - A992
  • [48] Linking microbial genes to mucosal metabolites uncovers host-microbial interactions during 5-ASA therapy for ulcerative colitis
    Jiang, L.
    Guo, M.
    Ruan, G.
    Zhou, R.
    Cao, Y.
    Bai, X.
    Yang, H.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i305 - i305
  • [49] Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease -: A systematic review
    Gisbert, JP
    Gomollón, F
    Maté, J
    Pajares, JM
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (03) : 471 - 488
  • [50] Optimizing use of 5-ASA in the treatment of ulcerative colitis: Focus on patient compliance and adherence
    Bernick, Steven J.
    Kane, Sunanda
    PATIENT-RELATED OUTCOME MEASURES, 2010, 1 : 57 - 63
12345